January 27th, 2015 · Leave a Comment
By Amy Beeman
In the final post of this blog, Dr. Gupreet Sandhu covers initial treatment of Acute Coronary Syndrome NSTEMI.
A 79-year-old male with a history of diabetes and hypertension awoke with chest pressure at 4 a.m. and this resolved after 45 minutes. He was seen in the Emergency Department the next morning at 8 a.m.
His current medications are metformin and hydrochlorothiazide.
His vital signs were as follows:
Blood pressure: 145/76
Pulse rate: 78
Respiration rate: 16
Normal cardiac and lung sounds
ECG: NSR rate 76 T wave inversion in V5, V6, aVL
CXR is normal
Troponin T 0.16
Which of the following is the most appropriate initial treatment?
A. Aspirin, heparin and ticagrelor
B. Aspirin, heparin and metoprolol
C. Aspirin, bivalirudin and prasugrel
D. Aspirin, heparin, clopidogrel and eptifibatide
January 20th, 2015 · Leave a Comment
By Amy Beeman
Today Dr. R. Todd Hurst offers a case study on the use of statins.
A 62-year-old Caucasian female is seen in your office for cardiovascular risk evaluation. She is asymptomatic and on no medications.
Her HDL cholesterol is 32 mg/dL, calculated LDL 130 mg/dL, triglycerides 225 mg/dL. The high sensitivity C-reactive protein is 3.7 mg/dL and fasting glucose is 120 mg/dL.
You recommend rosuvastatin 20 mg PO per day, but the patient is concerned about the medication increasing her risk for diabetes.
Which treatment is LEAST likely to increase the incidence of diabetes?
A. Atorvastatin 80 mg per day
B. Rosuvastatin 20 mg per day
C. Simvastatin 40 mg per day
D. Pravastatin 80 mg per day
E. Extended release niacin (Niaspan) 2000 mg per day
January 15th, 2015 · Leave a Comment
By Amy Beeman
Make plans now to escape the winter by attending one of our CV CME events in warmer climates.
Today, we highlight a trip to the Bahamas for the 4th Annual Innovations in Valve and Structural Heart Disease course:
Expert faculty use a case-based format to help you set up a heart team and multidisciplinary interventional program. This clinically oriented course will highlight innovations and recent developments in valvular and structural heart disease interventions. The course will review what you need to know regarding imaging and state-of-the-art treatment for aortic stenosis, mitral regurgitation, hypertrophic cardiomyopathy and left atrial appendage closure. Other challenging clinical problems, such as paravalvular regurgitation and patent foramen ovale closure, will also be discussed.
Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide CME for physicians.
Mayo Clinic College of Medicine designates this live activity for a maximum of 16 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation.
Atlantis Resort, Bahamas — April 2-4, 2015
For more information or to register, visit: Innovations in Valve and Structural Heart Disease.
For a complete list of courses, including other warm weather destinations, visit the CV CME Course Calendar.
January 13th, 2015 · Leave a Comment
By Amy Beeman
Dr. Steve Ommen offers a cardiomyopathy case study question today:
A 64-year-old female with hypertension presents for evaluation of new onset dyspnea on exertion. She has NYHA Class 2 symptoms. Her blood pressure is 118/70, pulse rate is 64. She is taking amlodipine 10 mg daily, metoprolol 25 mg twice daily, and aspirin 325 mg daily. An echocardiogram reveals hypertrophic cardiomyopathy, septal thickness of 22 mm with systolic anterior motion of the mitral valve, moderate mitral regurgitation and a left ventricular outflow tract gradient of 50 mmHg at rest, increasing to 80 with Valsalva maneuver. Which of the following should you recommend as the first step?
A. Discontinue amlodipine
B. Increase metoprolol
C. Septal myectomy
D. Septal ablation
January 8th, 2015 · Leave a Comment
By Amy Beeman
Mayo Clinic offers complimentary email newsletters for medical professionals.
It’s quick and easy to sign up — all you need is an email address.
To start receiving the bi-monthly clinical cardiology and cardiovascular surgery news from Mayo Clinic, subscribe here.
Today we share a video included in the most recent e-newsletter. Dr. Rob McBane, Director of Vascular Medicine at Mayo Clinic, leads a panel discussion titled “Abdominal Aortic Aneurisms: Update on Surveillance and Repair.” The video was originally posted on Medscape’s TheHeart.org.
The Heart Beat of Cardiology
December 11 - 13, 2014
Cardiology Update at South Beach: A Focus on Prevention
January 7 - 10, 2015
Hawaii Heart 2015
January 26 - 30, 2015
Arrhythmias & the Heart: A Cardiovascular Update
February 2 - 6, 2015
Cardiovascular Conference at Snowbird
February 13 - 16, 2015
Cardiology at Cancun: Topics in Clinical Cardiology
February 23 - 27, 2015
Echocardiographic Workshop on 2-D and Doppler Echocardiography at Vail
March 9 - 12, 2015
Innovative Valve and Structural Heart Disease
April 2 - 4, 2015
Case Studies from the Heart of Manhattan: A Mayo Clinic Cardiovascular Update
April 16 - 18, 2015
Imaging in Adult Congenital Heart Disease: Pearls for All Cardiac Providers
April 24 - 26, 2015
Echocardiography in the Nation's Capital
May 8 - 10, 2015
Page loaded in 1.001 seconds